These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36968998)

  • 61. Preoperative chemoradiotherapy in rectal cancer induces changes in the expression of nuclear β-catenin: prognostic significance.
    Gomez-Millan J; Perez L; Aroca I; Del Mar Delgado M; De Luque V; Román A; Torres E; Ramos S; Perez S; Bayo E; Medina JA
    BMC Cancer; 2014 Mar; 14():192. PubMed ID: 24629143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does neoadjuvant rectal score predict treatment outcomes better than the all grading systems used in neoadjuvantly treated rectal cancer?
    Sert F; Ozturk M; Yalman D; Ozkok S
    Asian J Surg; 2023 Oct; 46(10):4378-4384. PubMed ID: 36280480
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of interval between neoadjuvant chemoradiotherapy and surgery on disease recurrence and survival in rectal cancer: long-term results of a randomized clinical trial.
    Akgun E; Caliskan C; Bozbiyik O; Yoldas T; Doganavsargil B; Ozkok S; Kose T; Karabulut B; Elmas N; Ozutemiz O
    BJS Open; 2022 Sep; 6(5):. PubMed ID: 36254732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic Significance of Clinicopathological and Molecular Features After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients.
    Cho HJ; Baek JH; Baek DW; Kang BW; Lee SJ; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
    In Vivo; 2019; 33(6):1959-1965. PubMed ID: 31662525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Total neoadjuvant therapy or standard chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis.
    Ma Z; Tan L; Liu ZL; Xiao JW
    Front Surg; 2022; 9():911538. PubMed ID: 36090336
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
    Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
    Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).
    Serra-Aracil X; Pericay C; Badia-Closa J; Golda T; Biondo S; Hernández P; Targarona E; Borda-Arrizabalaga N; Reina A; Delgado S; Vallribera F; Caro A; Gallego-Plazas J; Pascual M; Álvarez-Laso C; Guadalajara-Labajo HG; Mora-Lopez L
    Ann Oncol; 2023 Jan; 34(1):78-90. PubMed ID: 36220461
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma.
    Ourô S; Mourato C; Velho S; Cardador A; Ferreira MP; Albergaria D; Castro RE; Maio R; Rodrigues CMP
    Front Oncol; 2020; 10():577653. PubMed ID: 33194696
    [No Abstract]   [Full Text] [Related]  

  • 70. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 72. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
    Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma.
    Aryan M; Read T; Goldstein L; Burriss N; Grajo JR; Moser P; George TJ; Tan S; Iqbal A
    Cureus; 2021 Oct; 13(10):e19037. PubMed ID: 34858737
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Baseline anaemia increases locally advanced rectal cancer mortality in older patients undergoing preoperative chemoradiation.
    Rodrigues D; Simões J; Teixeira L; Aires F; Fernandes C; Rey C; Sarmento C; Marques M
    Support Care Cancer; 2021 Mar; 29(3):1403-1411. PubMed ID: 32666216
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation.
    Wu J; Huang M; Wu Y; Hong Y; Cai L; He R; Luo Y; Wang P; Huang M; Lin J
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8897-8912. PubMed ID: 37154929
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improved response rate in patients with prognostically poor locally advanced rectal cancer after treatment with induction chemotherapy and chemoradiotherapy when compared with chemoradiotherapy alone: A matched case-control study.
    Voogt ELK; Schaap DP; van den Berg K; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Willems J; Cnossen JS; Peulen HMU; Nederend J; van Lijnschoten G; Burger JWA; Rutten HJT
    Eur J Surg Oncol; 2021 Sep; 47(9):2429-2435. PubMed ID: 34030921
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
    Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.